Navigation Links
Arizona Heart Innovative Technologies Licenses New Endovascular Device
Date:11/12/2008

PHOENIX, Nov. 12 /PRNewswire/ -- Arizona Heart Innovative Technologies, LLC (AHIT) announced the license of a new medical device for endovascular use to a publicly traded medical device company. "This is the second AHIT-developed product that we have licensed in the past ten months. We continue to demonstrate our ability to bridge the gap between good ideas from the medical community to commercially viable products for medical device companies. This confirms the viability of our business model to serve as a cost-effective supplementary research and development resource for companies," says AHIT President and CEO, Bill Colone. "We have additional products that have completed the development process and we are continuing to discuss options with many device companies."

AHIT licensed the endovascular product in July of 2007 from Hani Shennib, MD, a cardiovascular surgeon formerly at the Arizona Heart Hospital. The product was prototyped, tested and marketed to multiple medical companies immediately following positive clinical test results. The product should reach both the U.S. and international markets by the first quarter of 2009.

About Arizona Heart Innovative Technologies, LLC

Bill Colone, who co-founded AHIT in August 2006, has over 26 years of experience in developing and marketing medical devices. He served as President of Endomed, Inc. for over ten years, until its sale to LeMaitre Vascular (LMAT) in February 2005. Bill holds eleven US patents for medical devices with other applications pending.

AHIT provides a vehicle for evaluating and commercializing ideas from the medical community. This process includes product due diligence, market research, securing intellectual property rights, prototyping, and matching the product to the best medical device company through a sales process. The company's Scientific Advisory Board (SAB) consists of cardiovascular surgeons and endovascular specialists with over 80 years of experience trea
'/>"/>

SOURCE Arizona Heart Innovative Technologies, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
2. Arizona Pain Society and Dr. Robert Barkin, Rush University Medical Center, Present Program on Comprehensive Urine Drug Testing Sponsored by Dominion Diagnostics
3. VAP Cholesterol Test From Atherotech Covers 90 Percent of Arizona Insured
4. Arizona-Based SenesTech, Inc., Partners With Australia to Stop Starvation Due to Rice Shortages
5. ThirdBiotech Launches Research Institute to Promote Formation and Growth of Arizona-Based Biotech Companies
6. First Annual Arizona Biotech Day Announced for October 23rd 2008
7. Arizona Heart Institute First to Implant Powerlink XL in Phoenix, Arizona Since FDA Approval
8. Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel
9. ATS Medical Expands Open Pivot Heart Valve Offerings
10. Cardicas C-Port(R) Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed-Chest Heart Bypass Surgeries
11. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... The 6th Annual Arrowhead Personalized ... October 29-30 in San Francisco, CA. This year’s conference ... researchers and clinicians focused on addressing and solving the ... the twelve years since the sequencing of the human ... with pharmacogenetic information in the label and molecular diagnostics ...
(Date:8/20/2014)... your ear could improve the health of your heart, ... of Leeds used a standard TENS machine like those ... to the tragus, the small raised flap at the ... ear canal. , The stimulation changed the influence of ... nervous signals that can drive failing hearts too hard. ...
(Date:8/19/2014)... 2014 One of the major ... an inadequate vascular supply. Nutrient and gas transport ... is critical for successful regeneration and integration into ... deficiencies in vascularization and promote angiogenesis in a ... scaffold design and architecture, and enhancing scaffolds with ...
(Date:8/19/2014)... Pa. , Aug. 19, 2014 A ... has been nominated for a Centers for Disease Control ... addressing a major public health concern. ... System, is one of a team of researchers nominated ... Charles C. Shepard Science Award for Data Methods and ...
Breaking Biology Technology:6th Annual Personalized and Precision Medicine Conference Bringing Together Thought Leaders to Discuss Clinical Implementation, Dx Reimbursement, Big Data, and Sequencing 2'Tickling' your ear could be good for your heart 2Vascularization in Tissue Engineering Highlighted at 12th New Jersey Symposium on Biomaterials Science 2Geisinger investigator nominated for federal award 2Geisinger investigator nominated for federal award 3
... Jan. 9, 2012 Reportlinker.com announces ... is available in its catalogue: , ... Transplantation, Cord Blood Banking and Drug ... There is great interest ...
... Sequenom, Inc. (NASDAQ: SQNM ), a life ... of the Company,s 2011 performance and accomplishments, as well as ... Initial 2011 Performance Results ... for 2011 (unaudited). , Over 21,000 total prenatal and ...
... today that it has secured $47.5 million in Series ... financing along with existing investors OrbiMed Advisors, New Enterprise ... financing, Josh Bilenker, M.D., Partner at Aisling Capital, will ... round will support commercialization of the company,s Atlas™ System ...
Cached Biology Technology:Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development 2Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development 3Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development 4Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development 5Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development 6Sequenom Announces 2011 Operational Highlights and Early 2012 Outlook 2Sequenom Announces 2011 Operational Highlights and Early 2012 Outlook 3Sequenom Announces 2011 Operational Highlights and Early 2012 Outlook 4Roka Bioscience Secures $47.5 Million in Series D Financing 2
(Date:8/20/2014)... from the University of Tbingen, Arizona State University, the ... Public Health Institute (Swiss TPH) isolated Mycobacterium pinnipedii ... least 1000 years old. The pathogen is a relative ... occasionally causes disease in humans today. These researchers assume ... Peruvian coast. "The link to sea lions was unexpected" ...
(Date:8/20/2014)... that acral melanomas the rare type of skin cancer ... distinct from other more common types of skin cancer, according ... Pigment Cell & Melanoma Research . , Acral melanoma ... the feet, nail-beds and other hairless parts of the skin. ... by UV damage from the sun. , The team, from ...
(Date:8/20/2014)... and plastic bags could one day be made out ... scientists are now reporting. The novel process they developed ... with its agricultural and plastic waste problems, appear in ... Ilker S. Bayer and colleagues at the Italian Institute ... growing. In 2012, its production reached 288 million tons ...
Breaking Biology News(10 mins):Scientists learn more about rare skin cancer that killed Bob Marley 2
... , Cincinnati, (OH) - The International Rett Syndrome Foundation (IRSF) ... 18 new grants designed to study a variety of diverse ... and outcome measures for Rett syndrome. IRSF is the ... Rett syndrome research with the cumulative total of research spending ...
... German-based project is setting out to rescue biodiversity data at ... institutional databases, are kept in outdated digital storage systems, or ... Botanic Garden and Botanical Museum Berlin-Dahlem, provides a good example ... data. This is one of a set of data ...
... that is associated with the spread of cancer has won ... one of this year,s Kaye Innovation Awards at the university. ... of Prof. Chaim Gilon and Prof. Alexander Levitzki at the ... B (PKB, also called Akt). Since the activation of PKB ...
Cached Biology News:IRSF awards over $1.5 million for basic and translational research for Rett syndrome 2IRSF awards over $1.5 million for basic and translational research for Rett syndrome 3German research team targets 'at risk' data on biodiversity 2German research team targets 'at risk' data on biodiversity 3